Concurrent targeting of GSK3 and MEK as a therapeutic strategy to treat pancreatic ductal adenocarcinoma.
Fukuda J, Kosuge S, Satoh Y, Sekiya S, Yamamura R, Ooshio T, Hirata T, Sato R, Hatanaka KC, Mitsuhashi T, Nakamura T, Matsuno Y, Hatanaka Y, Hirano S, Sonoshita M.
Fukuda J, et al. Among authors: sekiya s.
Cancer Sci. 2024 Apr;115(4):1333-1345. doi: 10.1111/cas.16100. Epub 2024 Feb 6.
Cancer Sci. 2024.
PMID: 38320747
Free PMC article.